Document Detail

2-Aryloxymethylmorpholine histamine H(3) antagonists.
MedLine Citation:
PMID:  18922693     Owner:  NLM     Status:  MEDLINE    
The synthesis and biological activity of a new series of 2-aryloxymethylmorpholine histamine H(3) antagonists is described. The new compounds are high affinity histamine H(3) ligands that penetrate the CNS and occupy the histamine H(3) receptor in rat brain.
Michael A Letavic; John M Keith; Kiev S Ly; Pascal Bonaventure; Mark A Feinstein; Brian Lord; Kirsten L Miller; S Timothy Motley; Diane Nepomuceno; Steven W Sutton; Nicholas I Carruthers
Related Documents :
20480793 - Second-generation antihistamines for the treatment of chronic idiopathic urticaria.
7901803 - Regulation of astroglial responsiveness to neuroligands in primary culture.
14715243 - Nuclear import of n-terminal fak by activation of the fcepsilonri receptor in rbl-2h3 c...
Publication Detail:
Type:  Journal Article     Date:  2008-09-24
Journal Detail:
Title:  Bioorganic & medicinal chemistry letters     Volume:  18     ISSN:  1464-3405     ISO Abbreviation:  Bioorg. Med. Chem. Lett.     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2009-10-30     Completed Date:  2009-12-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9107377     Medline TA:  Bioorg Med Chem Lett     Country:  England    
Other Details:
Languages:  eng     Pagination:  5796-9     Citation Subset:  IM    
Johnson & Johnson Pharmaceutical Research & Development L.L.C., San Diego, CA 92121-1126, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Brain / metabolism
Histamine H3 Antagonists / chemical synthesis,  pharmacokinetics,  pharmacology*
Morpholines / chemical synthesis,  pharmacokinetics,  pharmacology*
Reg. No./Substance:
0/Histamine H3 Antagonists; 0/Morpholines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Application of a trifunctional reactive linker for the construction of antibody-drug hybrid conjugat...
Next Document:  Synthesis and structure-activity relationship of benzetimide derivatives as human CXCR3 antagonists.